MiNK Therapeutics shares surged 70% in pre-market trading after the company announced that its partner C-Further received up to $1.1 million in funding to advance pediatric cancer cell therapy research.
Show original
This funding will accelerate C-Further's research progress in the field of pediatric cancer cell therapy and provide strong support for the technological development of MiNK Therapeutics. The market has responded positively to this news, demonstrating investors' optimism about the company's future prospects.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
PoolX: Earn new token airdrops
Lock your assets and earn 10%+ APR
Lock now!
You may also like
Based: The BASED Token Airdrop Lookup Tool is now live
BlockBeats•2026/03/10 12:22
Trending news
MoreCrypto prices
More
Bitcoin
BTC
$70,436.72
+3.77%
Ethereum
ETH
$2,058.12
+3.09%
Tether USDt
USDT
$1
+0.01%
BNB
BNB
$645.86
+2.78%
XRP
XRP
$1.39
+2.60%
USDC
USDC
$1
+0.01%
Solana
SOL
$86.51
+3.42%
TRON
TRX
$0.2845
-0.08%
Dogecoin
DOGE
$0.09462
+4.48%
Cardano
ADA
$0.2632
+3.23%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now